Status:
TERMINATED
Sevoflurane and Isoflurane for RF or Cryo Ablation in Children.
Lead Sponsor:
Schneider Children's Medical Center, Israel
Conditions:
Supraventricular Tachycardia
Eligibility:
All Genders
8-14 years
Brief Summary
In children, radiofrequency catheter ablation (RFCA) or cryoablation are highly effective treatments for supraventricular tachycardia treatment. General anesthesia is often required to ensure comfort ...
Detailed Description
In children, radiofrequency catheter ablation (RFCA) or cryoablation are highly effective treatments for supraventricular tachycardia treatment. General anesthesia is often required to ensure comfort ...
Eligibility Criteria
Inclusion
- healthy patients aged 4 to 18 years, with an ASA physical status I or II, who are scheduled for elective radiofrequency ablation or cryoablation to treat SVT.
Exclusion
- patients with accompanying cardiac defects or other diseases, suspected Malignant Hyperthermia, contraindication to volatile anesthetics use and patients/ parental refusal.
Key Trial Info
Start Date :
November 1 2011
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
September 1 2013
Estimated Enrollment :
32 Patients enrolled
Trial Details
Trial ID
NCT01216501
Start Date
November 1 2011
End Date
September 1 2013
Last Update
November 20 2014
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Schneider Medical Center of Israel
Petah Tikva, Israel